StockNews.com assumed coverage on shares of vTv Therapeutics (NASDAQ:VTVT – Get Rating) in a research note issued to investors on Sunday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Separately, HC Wainwright restated a buy rating and issued a $6.00 price target on shares of vTv Therapeutics in a research report […]
StockNews.com initiated coverage on shares of vTv Therapeutics (NASDAQ:VTVT – Get Rating) in a research report released on Sunday. The firm issued a hold rating on the biotechnology company’s stock. Separately, HC Wainwright reissued a buy rating and set a $6.00 target price on shares of vTv Therapeutics in a research report on Tuesday, March […]
StockNews.com started coverage on shares of vTv Therapeutics (NASDAQ:VTVT – Get Rating) in a research report sent to investors on Saturday. The firm issued a hold rating on the biotechnology company’s stock. Separately, HC Wainwright restated a buy rating and issued a $6.00 target price on shares of vTv Therapeutics in a report on Tuesday, […]
StockNews.com assumed coverage on shares of vTv Therapeutics (NASDAQ:VTVT – Get Rating) in a research note issued to investors on Saturday. The firm set a “hold” rating on the biotechnology company’s stock. Separately, HC Wainwright restated a “buy” rating and issued a $6.00 price target on shares of vTv Therapeutics in a report on Tuesday, […]
StockNews.com assumed coverage on shares of vTv Therapeutics (NASDAQ:VTVT – Get Rating) in a research report report published on Friday morning. The firm issued a hold rating on the biotechnology company’s stock. Separately, HC Wainwright reissued a buy rating and set a $6.00 target price on shares of vTv Therapeutics in a research report on […]